Cognex Corporation - Common Stock (CGNX)
Healthcare › Industrial Instruments For Measurement, Display, and Control
Price History
Feb 9, 2026 — Aug 20, 2026Investment Snapshot
- Trading 307% above Graham Number — above intrinsic value estimate
- Piotroski F-Score 8/9 — financially strong with improving fundamentals
- ROE of 11.2% — below-average profitability
- Revenue growing at 9% annually
Cognex Corporation - Common Stock (CGNX) is a Healthcare company operating in Industrial Instruments For Measurement, Display, and Control, listed on the NASDAQ , with a market capitalisation of $10.5 billion . Key value metrics: P/E ratio 57.6, P/B ratio 6.46, Piotroski F-Score 8 out of 9 (strong financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
Cognex Corporation - Common Stock — Fundamental Analysis Summary
Cognex Corporation - Common Stock (CGNX) is currently trading 307% above its Graham Number of $15.38, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries an elevated trailing P/E ratio of 57.6x.
On financial health, CGNX shows a strong Piotroski F-Score of 8/9, indicating improving fundamentals across profitability, leverage, and efficiency, and modest return on equity of 11.2% (sector average: -20.1%), and manageable leverage with a debt-to-equity ratio of 0.35.
StockPik's composite Value Score for CGNX is 47/100 — reflecting current market or financial concerns. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
CGNX reports a high gross margin of 69.3% (sector average: 37.4%) and a strong operating margin of 22.7%.
CGNX shows revenue growing at 9% year-over-year, with earnings growing at 8%.
CGNX pays a modest dividend yield of 0.5%.